PDZ and LIM domain 1 pseudogene 2 (PDLIM1P2)

PDZ and LIM domain 1 pseudogene 2 (PDLIM1P2) is a processed pseudogene of the PDLIM1 gene, which encodes a cytoskeletal protein involved in actin-binding and various signaling pathways[3]. However, as a pseudogene, PDLIM1P2 does not encode a functional protein and is not considered a therapeutic or biological target. There is no direct evidence that PDLIM1P2 has a regulatory function or disease relevance, in contrast to some pseudogenes for other loci (such as PTENP1 for PTEN), which may have non-coding regulatory effects[1]. At present, there is no recognized biological, pathological, or pharmacological activity attributed to PDLIM1P2, and it does not serve as a target for drugs, disease modeling, or biomarker development[3]. Pseudogenes like PDLIM1P2 are generally non-functional remnants of genes that may contain sequence homology to their parental protein-coding gene but lack the ability to produce a functional protein[1][3]. Some pseudogenes may have regulatory RNA functions—such as acting as decoys for microRNAs—but there is no published evidence that PDLIM1P2 is biologically active in this way[1][3]. The protein-coding gene PDLIM1 (not PDLIM1P2) is a member of the PDZ-LIM family, involved in cytoskeletal organization and implicated in cancer and other physiological processes[2][4]. This functional context does not apply to the pseudogene PDLIM1P2[3]. “is_target” is false because pseudogenes (unless shown to have non-coding regulatory or pathological significance) are not considered therapeutic targets. In summary: PDLIM1P2 is a pseudogene with no evidence for biological function, druggability, or disease relevance. It is not a therapeutic or research target, and any attempt to use or refer to it as such would be incorrect[3].

Other names

PDLIM1P2PDZ and LIM domain protein 1 pseudogene 2